anaxirone has been researched along with Hematologic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becher, R; Beelen, DW; Ehrlich, R; Grosse-Wilde, H; Quabeck, K; Schaefer, UW; Schilcher, RB; Schmidt, U; Szy, D | 1 |
| Berdel, WE; Bremer, K; Peukert, M; Queisser, W; Wander, HE | 1 |
2 other study(ies) available for anaxirone and Hematologic Diseases
| Article | Year |
|---|---|
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Dogs; Drug Evaluation, Preclinical; Gastrointestinal Diseases; Hematologic Diseases; Triazoles; Whole-Body Irradiation | 1991 |
1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Triazoles | 1987 |